Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Combined Application of EBUS and EUS in Lung Cancer [NA]
A completed clinical trial evaluating the combined use of endobronchial ultrasound (EBUS) and endoscopic ultrasound (EUS) in non-small cell …
-
CLINICAL_TRIALS trial_result · 2012-10-17Clinical Trial Update: Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer [Phase 2]
Phase 2 trial results evaluate endostatin in combination with chemoradiotherapy for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-10-15Clinical Trial Update: Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 2]
This entry reports the completion of a Phase 2 trial evaluating combination chemotherapy in patients with stage IIIB or stage IV non-small c…
-
CLINICAL_TRIALS trial_result · 2012-10-08Clinical Trial Update: SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]
SWOG-9416 is a Phase 2 trial evaluating chemotherapy, radiation therapy, and surgery for stage III non-small cell lung cancer; the study sta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-10-04Clinical Trial Update: Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This Phase 1/2 clinical trial investigating a combination of gefitinib and sirolimus for recurrent or refractory stage IIIB/IV non-small cel…
-
CLINICAL_TRIALS withdrawal · 2012-10-04Clinical Trial Update: Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases [Phase 1]
A Phase 1 trial evaluating stereotactic radiosurgery with erlotinib for non-small cell lung cancer and brain metastases was withdrawn.
-
CLINICAL_TRIALS research · 2012-10-02Clinical Trial Update: De Novo Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors
This clinical trial update discusses de novo resistance to epidermal growth factor receptor-tyrosine kinase inhibitors in non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus Gemcitabine [Phase 2]
This ClinicalTrials.gov update reports the completion of a Phase 2 trial evaluating Zactima (vandetanib) in elderly patients with non-small …
-
CLINICAL_TRIALS trial_result · 2012-09-28Clinical Trial Update: SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients [Phase 4]
This document reports results from the Phase IV SELINE trial evaluating Iressa (gefitinib) as second-line therapy in non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial evaluating PET imaging tracers Fluorine F18-EF5 and Fludeoxyglucose F18 to assess hypoxia and glycolysis in stage I-I…
-
FDA approval · 2012-09-26FDA Approved: VINORELBINE — Original Application (Sagent Pharmaceuticals)
FDA approved the original ANDA for vinorelbine (VINORELBINE) from Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
This update reports the completion of a Phase 2 trial evaluating glufosfamide, with or without hydration, in patients with advanced non-smal…
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating acridine carboxamide in adults with advanced non-small cell lung cancer. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer [Phase 1]
This is a Phase 1 clinical trial update for high-dose 3-dimensional conformal radiation therapy in patients with inoperable Stage I, Stage I…
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial update on a combination chemotherapy regimen for metastatic ovarian cancer and non-small cell lung cancer, and the …
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 trial comparing sorafenib plus erlotinib versus erlotinib alone in previously treated advanced non-small-cell lung cancer has comple…
-
CLINICAL_TRIALS research · 2012-09-20Clinical Trial Update: Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer [Phase 2]
Phase II clinical trial investigating a double dose of icotinib for brain metastases in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating Endostar in combination with chemotherapy and radiotherapy for non-small cell lung cancer has completed. The stat…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This clinical trial update reports the completed Phase 2 study of CS-1008 with carboplatin/paclitaxel in chemotherapy-naïve patients with me…
-
CLINICAL_TRIALS trial_result · 2012-09-10Clinical Trial Update: Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma
This is an observational study update sponsored by AstraZeneca on the management of patients with non-small cell lung cancer (adenocarcinoma…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy [Phase 2]
A Phase 2 trial evaluating cetuximab for recurrent non-small cell lung cancer after prior therapy was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies [Phase 1]
Phase 1 safety study of a liposomal docetaxel formulation in patients with solid tumors who have failed prior therapy has been completed, ev…
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H... [Phase 2]
Phase II, multi-histology trial of fostamatinib disodium (R935788) in advanced colorectal, non-small cell lung, head and neck, hepatocellula…
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: Chemotherapy in Treating Patients With Lung Cancer
A Eli Lilly-sponsored chemotherapy trial for non-small cell lung cancer has completed.